HomeAI · summaries
Storia in 9 fonti
CVS Caremark to cover Foundayo, Zepbound obesity drugs - UPI.com
CVS Caremark will start covering Eli Lilly's Foundayo and resume covering its Zepbound obesity drugs in the next several months, the companies said.
Confronto fonti
6 prospettive sulla stessa storiaTimeline cronologica
- ·
biopharmadive.com
CVS obesity drug deal puts Lilly on equal footing with Novo
The agreement includes Lilly’s new pill Foundayo and restores coverage for Zepbound, erasing what had been a commercial edge for rival Novo Nordisk.
- ·
nbcnews.com
CVS Caremark will cover Lilly’s weight loss drug Zepbound once again
The pharmacy benefits manager also plans to add the weight loss pill Foundayo to its formulary next month.
